Neurodegenerative diseases are among the most pressing and devastating health challenges facing aging populations globally.
- Our group aims to develop therapies to prevent, slow or reverse neurodegenerative disease, and to match these therapies with individual patients.
- We combine molecular- and cellular-level understanding of protein-misfolding, a central pathological process in neurodegeneration, with genomics, stem cell technologies and innovative clinical trial design.